Search results for "FDA approval"

YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.

YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.

YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business agreement with Huinno to spearhead...
Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Alteogen announced on the 12th that it has secured registration with the United States Patent and Trademark Office for a formulation patent related...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

FDA Approves Clinical Trial for Abl Bio’s Dual-Antibody ADC Candidate

Abl Bio announced on March 3rd that the U.S. Food and Drug Administration has approved the Investigational New Drug...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...
Treating Depression with Brain Stimulation Without Medication

Treating Depression with Brain Stimulation Without Medication

The Busan On Hospital Mental Health Promotion Center (Director Kim Sang-yeop) has introduced Transcranial Magnetic...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?

The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?

A, who has entered her mid-40s this year, has been feeling increasingly depressed when standing in front of the mirror...
BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

BMS Rare Heart Disease Drug 'Camzyos' Opens Prescription Path for Adolescents

The hypertrophic cardiomyopathy treatment drug 'Camzyos (generic name mavacamten)' is expected to be prescribed for...